These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34678489)

  • 1. Receptors and ligands for herpes simplex viruses: Novel insights for drug targeting.
    Huang Y; Song Y; Li J; Lv C; Chen ZS; Liu Z
    Drug Discov Today; 2022 Jan; 27(1):185-195. PubMed ID: 34678489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.
    Tiwari V; Liu J; Valyi-Nagy T; Shukla D
    J Biol Chem; 2011 Jul; 286(28):25406-15. PubMed ID: 21596749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
    Yoon M; Zago A; Shukla D; Spear PG
    J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A boost to the antiviral activity: Cholesterol tagged peptides derived from glycoprotein B of Herpes Simplex virus type I.
    Lombardi L; Falanga A; Del Genio V; Palomba L; Galdiero M; Franci G; Galdiero S
    Int J Biol Macromol; 2020 Nov; 162():882-893. PubMed ID: 32569683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium.
    Akhtar J; Tiwari V; Oh MJ; Kovacs M; Jani A; Kovacs SK; Valyi-Nagy T; Shukla D
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4026-35. PubMed ID: 18502984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.
    Stiles KM; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ; Krummenacher C
    J Virol; 2010 Nov; 84(22):11646-60. PubMed ID: 20826693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nectin-1 and Herpesvirus Entry Mediator as Cellular Receptors for Herpes Simplex Virus 1 on Primary Murine Dermal Fibroblasts.
    Petermann P; Rahn E; Thier K; Hsu MJ; Rixon FJ; Kopp SJ; Knebel-Mörsdorf D
    J Virol; 2015 Sep; 89(18):9407-16. PubMed ID: 26136572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.
    Zheng K; Chen M; Xiang Y; Ma K; Jin F; Wang X; Wang X; Wang S; Wang Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):990-6. PubMed ID: 24657267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
    Krummenacher C; Baribaud F; Ponce de Leon M; Baribaud I; Whitbeck JC; Xu R; Cohen GH; Eisenberg RJ
    Virology; 2004 May; 322(2):286-99. PubMed ID: 15110526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Sides to Every Story: Herpes Simplex Type-1 Viral Glycoproteins gB, gD, gH/gL, gK, and Cellular Receptors Function as Key Players in Membrane Fusion.
    Jambunathan N; Clark CM; Musarrat F; Chouljenko VN; Rudd J; Kousoulas KG
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.
    Uchida H; Shah WA; Ozuer A; Frampton AR; Goins WF; Grandi P; Cohen JB; Glorioso JC
    J Virol; 2009 Apr; 83(7):2951-61. PubMed ID: 19129446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.
    Patrusheva I; Perelygina L; Torshin I; LeCher J; Hilliard J
    J Virol; 2016 Oct; 90(20):9420-32. PubMed ID: 27512063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entry mechanisms of herpes simplex virus 1 into murine epidermis: involvement of nectin-1 and herpesvirus entry mediator as cellular receptors.
    Petermann P; Thier K; Rahn E; Rixon FJ; Bloch W; Özcelik S; Krummenacher C; Barron MJ; Dixon MJ; Scheu S; Pfeffer K; Knebel-Mörsdorf D
    J Virol; 2015 Jan; 89(1):262-74. PubMed ID: 25320325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
    Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry.
    O'Donnell CD; Kovacs M; Akhtar J; Valyi-Nagy T; Shukla D
    Virology; 2010 Feb; 397(2):389-98. PubMed ID: 20004926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the antiviral potential of the soluble forms of glycoprotein D receptors on ocular herpes caused by HSV-1 and HSV-2 infections in a transgenic mouse model.
    Fujimoto Y; Hikita SI; Takeda K; Ozaki K; Inoue H; Takakuwa H; Sonoda KH; Ono E
    J Med Virol; 2019 May; 91(5):820-828. PubMed ID: 30575982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
    Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
    Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein D actively induces rapid internalization of two nectin-1 isoforms during herpes simplex virus entry.
    Stiles KM; Krummenacher C
    Virology; 2010 Mar; 399(1):109-119. PubMed ID: 20089288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimers functionalized with membrane-interacting peptides for viral inhibition.
    Tarallo R; Carberry TP; Falanga A; Vitiello M; Galdiero S; Galdiero M; Weck M
    Int J Nanomedicine; 2013; 8():521-34. PubMed ID: 23429490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.